Health
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial – The Lancet
CoronaVac was well tolerated and safe and induced humoral responses in children andadolescents aged 3–17 years. Neutralising…
We use cookies to help provide and enhance our service and tailor content and ads. To update your cookie settings, please visit the Cookie Preference Center for this site.Copyright © 2021 Elsevier Inc. except certain content provided by third parties. The…
Continue Reading
-
Noosa News21 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News22 hours agoYoung voices shape Sunshine Coast’s future
-
Business22 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News19 hours agoCopperString transmission line projected to cost almost $14b amid massive blowout